custom image

Joint meeting with: Diabetes: Many Faces of the Disease

Obesity: From Cell to Patient

February 1-3, 2021 | 10:00AM EST | 3:00PM UTC*
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

Obesity is a chronic disease affecting millions of people world-wide, and is often associated with numerous co-morbidities, including Type II diabetes, liver disease and cardiovascular disease. This conference aims to gather the world leaders in obesity research and discuss numerous topics- from the cell to the patient- as they relate to obesity. Obesity is an annual topic for Keystone Symposia and is considered to be one of the most critical in the field and the previous Keystone Symposia conferences have been heavily focused on basic research. Therefore, this conference program particularly aims to address this gap by providing a greater balance with clinical/translational research on the program. Additionally, there are sessions that have a special focus on the gut/brain axis, including the microbiota, as there is emerging research in this area that has made transformational steps in our understanding of etiology of this disease, as well as in treatment. Moreover, there is strong evidence that the gut/brain axis is important not just for appetitive behavior but also energy homeostasis, blood glucose and even emotional state. Finally, this conference is being held jointly with the annual diabetes conference, Diabetes: Many Faces of the Disease, as there is obvious overlap in these fields. Therefore, the program will contain joint sessions and even a joint Keynote speaker. With this pairing, it is anticipated to draw the leaders in this field from around the world, as well as the next generation of future scientists. Connecting scientists in basic, transitional, clinical and pharmaceutical research will be crucial to moving the field forward.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission:
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: January 22, 2021
Financial Aid Application: Passed

*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk


Program Details

Keynote Speaker

Morris White, PhD

Morris F. White, PhD
Boston Children's Hospital, Harvard Medical School

Speaking at this eSymposia

Rachel L. Batterham

University College London, UK

Hans Rudolf Berthoud

Pennington Biomedical Research Center, USA

Diego V. Bohórquez

Duke University Medical Center, USA

Michael A. Cowley

Monash University, Australia

Ana Domingos

University of Oxford, UK

Carmella Evans-Molina

Indiana University, USA

Stephanie E. Fulton

University of Montreal, Canada

Carla J. Greenbaum

Benaroya Research Institute at Virginia Mason, USA

Sean M. Hartig

Baylor College of Medicine, USA

Shane T. Hentges

Colorado State University, USA

Alka M. Kanaya

University of California, San Francisco, USA

Lotte Bjerre Knudsen

Novo Nordisk A/S, Denmark

Michael Krashes

NIDDK, National Institutes of Health, USA

Rory J. McCrimmon

University of Dundee, UK

Martin G. Myers Jr.

University of Michigan, USA

Max Nieuwdorp

University of Amsterdam, Netherlands

Mary-Elizabeth Patti

Joslin Diabetes Center, USA

Linda Rinaman

Florida State University, USA

Darleen A. Sandoval

University of Colorado, USA

Camilla Charlotte Schéele

University of Copenhagen, Denmark

Philipp E. Scherer

University of Texas Southwestern Medical Center, USA

Gary J. Schwartz

Albert Einstein College of Medicine, USA

Michael W. Schwartz

University of Washington, USA

Dana M. Small

Yale University School of Medicine, USA

Elinor L. Sullivan

Oregon National Primate Research Center, USA

Roy Taylor

Newcastle University, UK

Murielle M. Veniant

Amgen Inc., USA

Stephanie Wesolowski

University of Colorado Denver, USA

Morris F. White

Boston Children's Hospital, Harvard Medical School, USA

Lori M. Zeltser

Columbia University, USA




Additional Support





Funding for this conference was made possible (in part) by Grant No. 1 R13 DK127724-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Media-in-Kind Support









This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Donate to Keystone Symposia

custom image